Early free light chain reduction following treatment initiation predicts favorable outcome in intact immunoglobulin myeloma

Blood Cancer J. 2022 Jan 5;12(1):3. doi: 10.1038/s41408-021-00600-6.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Disease Management
  • Female
  • Humans
  • Immunoglobulin Heavy Chains / blood*
  • Immunoglobulin Light Chains / blood*
  • Male
  • Middle Aged
  • Multiple Myeloma / blood
  • Multiple Myeloma / therapy*
  • Progression-Free Survival
  • Prospective Studies

Substances

  • Immunoglobulin Heavy Chains
  • Immunoglobulin Light Chains